GeneDx Holdings Corp. (WGS)
64.69
+1.95
(+3.11%)
USD |
NASDAQ |
Oct 28, 16:00
64.69
0.00 (0.00%)
After-Hours: 17:58
GeneDx Holdings Price to Book Value : 7.894 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 7.656 |
| October 26, 2026 | 7.476 |
| October 23, 2026 | 6.852 |
| October 22, 2026 | 8.193 |
| October 21, 2026 | 8.413 |
| October 20, 2026 | 8.389 |
| October 19, 2026 | 8.090 |
| October 16, 2026 | 7.763 |
| October 15, 2026 | 8.569 |
| October 14, 2026 | 8.373 |
| October 13, 2026 | 7.927 |
| October 12, 2026 | 7.788 |
| October 09, 2026 | 8.216 |
| October 08, 2026 | 8.265 |
| October 07, 2026 | 8.363 |
| October 06, 2026 | 8.728 |
| October 05, 2026 | 9.308 |
| October 02, 2026 | 8.919 |
| October 01, 2026 | 8.660 |
| September 30, 2026 | 8.823 |
| September 29, 2026 | 9.249 |
| September 28, 2026 | 10.49 |
| September 25, 2026 | 10.79 |
| September 24, 2026 | 10.80 |
| September 23, 2026 | 10.40 |
| Date | Value |
|---|---|
| September 22, 2026 | 11.08 |
| September 21, 2026 | 11.94 |
| September 18, 2026 | 12.34 |
| September 17, 2026 | 12.81 |
| September 16, 2026 | 11.89 |
| September 15, 2026 | 11.55 |
| September 14, 2026 | 10.95 |
| September 11, 2026 | 10.41 |
| September 10, 2026 | 10.25 |
| September 09, 2026 | 10.55 |
| September 08, 2026 | 10.48 |
| September 04, 2026 | 10.49 |
| September 03, 2026 | 10.66 |
| September 02, 2026 | 10.58 |
| September 01, 2026 | 10.35 |
| August 31, 2026 | 10.35 |
| August 28, 2026 | 10.54 |
| August 27, 2026 | 10.89 |
| August 26, 2026 | 11.02 |
| August 25, 2026 | 10.67 |
| August 24, 2026 | 10.40 |
| August 21, 2026 | 10.62 |
| August 20, 2026 | 10.07 |
| August 19, 2026 | 9.72 |
| August 18, 2026 | 9.316 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 24.40 |
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | -- |
| Intellia Therapeutics, Inc. | 2.561 |
| 10X Genomics, Inc. | 13.19 |
Price to Book Value Related Metrics
| PS Ratio | 4.160 |
| Price | 64.69 |
| Earnings Yield | -5.61% |
| Market Cap | 1.928B |